Skin Lightening Study – Enrolment Data Assuming that the scope of the clinical trial indicates the potential product(s), it also points to the targeted market: North America.
Project | Treatment for? | Participants | Duration |
Skin Lightening Study | Uneven Skin Tone Facial Brown Spots | Healthy Females Ages 25-70 | 12 weeks 4 visits |
For more information:
https://www.zoedraelos.com/drzoe/study/51/#main
What’s about the “Proof of Efficacy” for the Asian market (accounting for around 90% of the global skin-lightening market) or more precisely for the “skin whitener” cream (extensively advertised by SBM in the recent years)? Will it follow after having the results of this first "clinial trial" or will it be performed independently? By SBM or by the potential Asian partner?
GLTA
Haiduk